REVIEW ARTICLE
Mechanisms of apoptosis modulation by curcumin: Implications for cancer therapy
Keywan Mortezaee,
Ensieh Salehi,
Hanifeh Mirtavoos-mahyari,
Elahe Motevaseli,
Masoud Najafi,
Bagher Farhood,
Rhonda J. Rosengren,
Amirhossein Sahebkar,
Keywan Mortezaee
Department of Anatomy, School of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran
Search for more papers by this authorEnsieh Salehi
Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Search for more papers by this authorHanifeh Mirtavoos-mahyari
Department of Medical Genetics, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Search for more papers by this authorElahe Motevaseli
Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
Search for more papers by this authorCorresponding Author
Masoud Najafi
Radiology and Nuclear Medicine Department, School of Paramedical Sciences, Kermanshah University of Medical Science, Kermanshah, Iran
Correspondence Masoud Najafi, Radiology and Nuclear Medicine Department, School of Paramedical Sciences, Kermanshah University of Medical Science, Kermanshah 6715847141, Iran. Email: [email protected]
Bagher Farhood, Department of Medical Physics and Radiology, Faculty of Paramedical Sciences, Kashan University of Medical Sciences, Kashan 8713781147, Iran. Email: [email protected]
Amirhossein Sahebkar, Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran. Email: [email protected]; [email protected]
Search for more papers by this authorCorresponding Author
Bagher Farhood
Department of Medical Physics and Radiology, Faculty of Paramedical Sciences, Kashan University of Medical Sciences, Kashan, Iran
Correspondence Masoud Najafi, Radiology and Nuclear Medicine Department, School of Paramedical Sciences, Kermanshah University of Medical Science, Kermanshah 6715847141, Iran. Email: [email protected]
Bagher Farhood, Department of Medical Physics and Radiology, Faculty of Paramedical Sciences, Kashan University of Medical Sciences, Kashan 8713781147, Iran. Email: [email protected]
Amirhossein Sahebkar, Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran. Email: [email protected]; [email protected]
Search for more papers by this authorRhonda J. Rosengren
Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand
Search for more papers by this authorCorresponding Author
Amirhossein Sahebkar
Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
Correspondence Masoud Najafi, Radiology and Nuclear Medicine Department, School of Paramedical Sciences, Kermanshah University of Medical Science, Kermanshah 6715847141, Iran. Email: [email protected]
Bagher Farhood, Department of Medical Physics and Radiology, Faculty of Paramedical Sciences, Kashan University of Medical Sciences, Kashan 8713781147, Iran. Email: [email protected]
Amirhossein Sahebkar, Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran. Email: [email protected]; [email protected]
Search for more papers by this author
Keywan Mortezaee,
Ensieh Salehi,
Hanifeh Mirtavoos-mahyari,
Elahe Motevaseli,
Masoud Najafi,
Bagher Farhood,
Rhonda J. Rosengren,
Amirhossein Sahebkar,
Keywan Mortezaee
Department of Anatomy, School of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran
Search for more papers by this authorEnsieh Salehi
Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Search for more papers by this authorHanifeh Mirtavoos-mahyari
Department of Medical Genetics, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Search for more papers by this authorElahe Motevaseli
Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
Search for more papers by this authorCorresponding Author
Masoud Najafi
Radiology and Nuclear Medicine Department, School of Paramedical Sciences, Kermanshah University of Medical Science, Kermanshah, Iran
Correspondence Masoud Najafi, Radiology and Nuclear Medicine Department, School of Paramedical Sciences, Kermanshah University of Medical Science, Kermanshah 6715847141, Iran. Email: [email protected]
Bagher Farhood, Department of Medical Physics and Radiology, Faculty of Paramedical Sciences, Kashan University of Medical Sciences, Kashan 8713781147, Iran. Email: [email protected]
Amirhossein Sahebkar, Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran. Email: [email protected]; [email protected]
Search for more papers by this authorCorresponding Author
Bagher Farhood
Department of Medical Physics and Radiology, Faculty of Paramedical Sciences, Kashan University of Medical Sciences, Kashan, Iran
Correspondence Masoud Najafi, Radiology and Nuclear Medicine Department, School of Paramedical Sciences, Kermanshah University of Medical Science, Kermanshah 6715847141, Iran. Email: [email protected]
Bagher Farhood, Department of Medical Physics and Radiology, Faculty of Paramedical Sciences, Kashan University of Medical Sciences, Kashan 8713781147, Iran. Email: [email protected]
Amirhossein Sahebkar, Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran. Email: [email protected]; [email protected]
Search for more papers by this authorRhonda J. Rosengren
Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand
Search for more papers by this authorCorresponding Author
Amirhossein Sahebkar
Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
Correspondence Masoud Najafi, Radiology and Nuclear Medicine Department, School of Paramedical Sciences, Kermanshah University of Medical Science, Kermanshah 6715847141, Iran. Email: [email protected]
Bagher Farhood, Department of Medical Physics and Radiology, Faculty of Paramedical Sciences, Kashan University of Medical Sciences, Kashan 8713781147, Iran. Email: [email protected]
Amirhossein Sahebkar, Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran. Email: [email protected]; [email protected]
Search for more papers by this authorAbstract
Cancer incidences are growing and cause millions of deaths worldwide. Cancer therapy is one of the most important challenges in medicine. Improving therapeutic outcomes from cancer therapy is necessary for increasing patients’ survival and quality of life. Adjuvant therapy using various types of antibodies or immunomodulatory agents has suggested modulating tumor response. Resistance to apoptosis is the main reason for radioresistance and chemoresistance of most of the cancers, and also one of the pivotal targets for improving cancer therapy is the modulation of apoptosis signaling pathways. Apoptosis can be induced by intrinsic or extrinsic pathways via stimulation of several targets, such as membrane receptors of tumor necrosis factor-α and transforming growth factor-β, and also mitochondria. Curcumin is a naturally derived agent that induces apoptosis in a variety of different tumor cell lines. Curcumin also activates redox reactions within cells inducing reactive oxygen species (ROS) production that leads to the upregulation of apoptosis receptors on the tumor cell membrane. Curcumin can also upregulate the expression and activity of p53 that inhibits tumor cell proliferation and increases apoptosis. Furthermore, curcumin has a potent inhibitory effect on the activity of NF-κB and COX-2, which are involved in the overexpression of antiapoptosis genes such as Bcl-2. It can also attenuate the regulation of antiapoptosis PI3K signaling and increase the expression of MAPKs to induce endogenous production of ROS. In this paper, we aimed to review the molecular mechanisms of curcumin-induced apoptosis in cancer cells. This action of curcumin could be applicable for use as an adjuvant in combination with other modalities of cancer therapy including radiotherapy and chemotherapy.
CONFLICTS OF INTEREST
The authors declare that they have no conflicts of interest.
REFERENCES
- Abdel Shakor, A. B., Atia, M., Alshehri, A. S., Sobota, A., & Kwiatkowska, K. (2015). Ceramide generation during curcumin-induced apoptosis is controlled by crosstalk among Bcl-2, Bcl-xL, caspases and glutathione. Cellular Signalling, 27(11), 2220–2230.
- Abdel Shakor, A. B., Atia, M., Ismail, I. A., Alshehri, A., El-Refaey, H., Kwiatkowska, K., & Sobota, A. (2014). Curcumin induces apoptosis of multidrug-resistant human leukemia HL60 cells by complex pathways leading to ceramide accumulation. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1841(12), 1672–1682.
- Abdollahi, E., Momtazi, A. A., Johnston, T. P., & Sahebkar, A. (2018). Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades? Journal of Cellular Physiology, 233(2), 830–848.
- Afrin, L. B., & Ergul, S. M. (2000). Medical therapy of prostate cancer: 1999. Journal of the South Carolina Medical Association (1975), 96(2), 77–84.
- Akaza, H. (2007). Global update on defining and treating high-risk localized prostate cancer with leuprorelin: A Japanese perspective--the effect of primary androgen deprivation therapy on stage C prostate cancer. BJU International, 99(Suppl 1), 10–12.
- Almasan, A., & Ashkenazi, A. (2003). Apo2L/TRAIL: Apoptosis signaling, biology, and potential for cancer therapy. Cytokine & Growth Factor Reviews, 14(3-4), 337–348.
- Amaral, J. D., Xavier, J. M., Steer, C. J., & Rodrigues, C. M. (2010). Targeting the p53 pathway of apoptosis. Current Pharmaceutical Design, 16(22), 2493–2503.
- Amini, P., Mirtavoos-Mahyari, H., Motevaseli, E., Shabeeb, D., Musa, A. E., Cheki, M., … Najafi, M. (2018). Mechanisms for radioprotection by melatonin; can it be used as a radiation countermeasure? Current Molecular Pharmacology, 11. Advance online publication. https://doi.org/10.2174/1874467211666180802164449
- Antunes, L. M. G., Araújo, M. C. P., Darin, J. D. C., & Bianchi, M. L. P. (2000). Effects of the antioxidants curcumin and vitamin C on cisplatin-induced clastogenesis in Wistar rat bone marrow cells. Mutation Research, 465(1-2), 131–137.
- Aravindan, N., Madhusoodhanan, R., Ahmad, S., Johnson, D., & Herman, T. S. (2008). Curcumin inhibits NFκB mediated radioprotection and modulate apoptosis related genes in human neuroblastoma cells. Cancer Biology & Therapy, 7(4), 569–576.
- Aubrey, B. J., Kelly, G. L., Janic, A., Herold, M. J., & Strasser, A. (2018). How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death and Differentiation, 25(1), 104–113.
- Baatout, S., Derradji, H., Jacquet, P., & Mergeay, M. (2005). Increased radiation sensitivity of an eosinophilic cell line following treatment with epigallocatechin-gallate, resveratrol and curcuma. International Journal of Molecular Medicine, 15(2), 337–352.
- Baatout, S., Derradji, H., Jacquet, P., Ooms, D., Michaux, A., & Mergeay, M. (2004). Effect of curcuma on radiation-induced apoptosis in human cancer cells. International Journal of Oncology, 24(2), 321–329.
- Bagheri, H., Rezapour, S., Najafi, M., Motevaseli, E., Shekarchi, B., Cheki, M., & Mozdarani, H. (2018). Protection against radiation-induced micronuclei in rat bone marrow erythrocytes by Curcumin and selenium L-methionine. Iranian Journal of Medical Sciences, 43, 645–652.
- Balcer-Kubiczek, E. K. (2012). Apoptosis in radiation therapy: A double-edged sword. Experimental Oncology, 34(3), 277–285.
- Barnett, G. C., West, C. M. L., Dunning, A. M., Elliott, R. M., Coles, C. E., Pharoah, P. D. P., & Burnet, N. G. (2009). Normal tissue reactions to radiotherapy: Towards tailoring treatment dose by genotype. Nature Reviews Cancer, 9(2), 134–142.
- Baud, V., & Karin, M. (2009). Is NF-κB a good target for cancer therapy? Hopes and pitfalls. Nature Reviews Drug Discovery, 8(1), 33–40.
- Bertolini, M., Sobue, T., Thompson, A., & Dongari-Bagtzoglou, A. (2017). Chemotherapy induces oral mucositis in mice without additional noxious stimuli(). Translational Oncology, 10(4), 612–620.
- Bold, R. J., Termuhlen, P. M., & McConkey, D. J. (1997). Apoptosis, cancer and cancer therapy. Surgical Oncology, 6(3), 133–142.
- Bours, V., Bentires-Alj, M., Hellin, A. C., Viatour, P., Robe, P., Delhalle, S., … Merville, M. P. (2000). Nuclear factor-kappa B, cancer, and apoptosis. Biochemical Pharmacology, 60(8), 1085–1089.
- Braun, T., Carvalho, G., Fabre, C., Grosjean, J., Fenaux, P., & Kroemer, G. (2006). Targeting NF-κB in hematologic malignancies. Cell Death and Differentiation, 13, 748–758.
- Brown, J. M., & Wouters, B. G. (1999). Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Research, 59(7), 1391–1399.
- Buchholz, T. A., Garg, A. K., Chakravarti, N., Aggarwal, B. B., Esteva, F. J., Kuerer, H. M., … Sahin, A. A. (2005). The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer. Clinical Cancer Research, 11(23), 8398–8402.
- Buhrmann, C., Mobasheri, A., Busch, F., Aldinger, C., Stahlmann, R., Montaseri, A., & Shakibaei, M. (2011). Curcumin modulates nuclear factor κB (NF-κB)-mediated inflammation in human tenocytes in vitro: Role of the phosphatidylinositol 3-kinase/Akt pathway. The Journal of Biological Chemistry, 286(32), 28556–28566.
- Bush, J. A., Cheung, K. J. J., Jr., & Li, G. (2001). Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Experimental Cell Research, 271(2), 305–314.
- Cain, K., Bratton, S. B., & Cohen, G. M. (2002). The Apaf-1 apoptosome: A large caspase-activating complex. Biochimie, 84(2-3), 203–214.
- Calaf, G. M., Echiburú-Chau, C., Wen, G., Balajee, A. S., & Roy, D. (2012). Effect of curcumin on irradiated and estrogen-transformed human breast cell lines. International Journal of Oncology, 40(2), 436–442.
- Chai, Y., Lam, R. K. K., Calaf, G. M., Zhou, H., Amundson, S., & Hei, T. K. (2013). Radiation-induced non-targeted response in vivo: Role of the TGFβ-TGFBR1-COX-2 signalling pathway. British Journal of Cancer, 108(5), 1106–1112.
- Chai, Y., Calaf, G. M., Zhou, H., Ghandhi, S. A., Elliston, C. D., Wen, G., … Hei, T. K. (2012). Radiation induced COX-2 expression and mutagenesis at non-targeted lung tissues of gpt delta transgenic mice. British Journal of Cancer, 108(1), 91–98.
- Cheki, M., Yahyapour, R., Farhood, B., Rezaeyan, A., Shabeeb, D., Amini, P., … Najafi, M. (2018). COX-2 in radiotherapy: A potential target for radioprotection and radiosensitization. Current Molecular Pharmacology, 11(3), 173–183.
- Chen, J., Xu, T., & Chen, C. (2015). The critical roles of miR-21 in anti-cancer effects of curcumin. Annals of Translational Medicine, 3(21), 330.
- Chen, X., Kandasamy, K., & Srivastava, R. K. (2003). Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling. Cancer Research, 63(5), 1059–1066.
- Chen, X., Wang, J., Fu, Z., Zhu, B., Wang, J., Guan, S., & Hua, Z. (2017). Curcumin activates DNA repair pathway in bone marrow to improve carboplatin-induced myelosuppression. Scientific Reports, 7(1), 17724.
- Chon, Y. E., Seong, J., Kim, B. K., Cha, J., Kim, S. U., Park, J. Y., … Kim, D. Y. (2011). Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: Endoscopic findings and risk factors. International Journal of Radiation Oncology, Biology, Physics, 81(5), 1343–1351.
- Choudhuri, T., Pal, S., Agwarwal, M. L., Das, T., & Sa, G. (2002). Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Letters, 512(1-3), 334–340.
- Cicero, A. F. G., Colletti, A., Bajraktari, G., Descamps, O., Djuric, D. M., Ezhov, M., … Banach, M. (2017). Lipid lowering nutraceuticals in clinical practice: Position paper from an International Lipid Expert Panel. Archives of Medical Science, 13(5), 965–1005.
- Collett, G. P., & Campbell, F. C. (2004). Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells. Carcinogenesis, 25(11), 2183–2189.
- Dange, P., Yadav, H., Kumar, V., Bhilwade, H., Pandey, B., & Sarma, H. (2017). Modification of radiation-induced murine thymic lymphoma incidence by curcumin. Journal of Radiation and Cancer Research, 8(3), 141.
10.4103/jrcr.jrcr_32_17 Google Scholar
- Deeb, D., Xu, Y. X., Jiang, H., Gao, X., Janakiraman, N., Chapman, R. A., & Gautam, S. C. (2003). Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in lncap prostate cancer cells1. Molecular Cancer Therapeutics, 2(1), 95–103.
- Deeb, D., Jiang, H., Gao, X., Hafner, M. S., Wong, H., Divine, G., … Gautam, S. C. (2004). Curcumin sensitizes prostate cancer cells to tumor necrosis factor–related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-κB through suppression of IκBα phosphorylation. Molecular Cancer Therapeutics, 3(7), 803–812.
- Duran, A., Linares, J. F., Galvez, A. S., Wikenheiser, K., Flores, J. M., Diaz-Meco, M. T., & Moscat, J. (2008). The signaling adaptor p62 is an important NF-κB mediator in tumorigenesis. Cancer Cell, 13(4), 343–354.
- Elmore, S. (2007). Apoptosis: A review of programmed cell death. Toxicologic Pathology, 35(4), 495–516.
- Elumalai, P., Gunadharini, D. N., Senthilkumar, K., Banudevi, S., Arunkumar, R., Benson, C. S., … Arunakaran, J. (2012). Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway. Toxicology Letters, 215(2), 131–142.
- Eriksson, D., & Stigbrand, T. (2010). Radiation-induced cell death mechanisms. Tumour Biology, 31(4), 363–372.
- Farhood, B., Najafi, M., & Mortezaee, K. (2018). Cancer-associated fibroblasts: Secretions, interactions, and therapy. Journal of Cellular Biochemistry
- Farhood, B., Goradel, N. H., Mortezaee, K., Khanlarkhani, N., Najafi, M., & Sahebkar, A. (2018). Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment. Journal of Cellular Physiology
- Farhood, B., Goradel, N. H., Mortezaee, K., Khanlarkhani, N., Salehi, E., Nashtaei, M. S., & Najafi, M. (2018). Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization. Clinical and Translational Oncology.
- Farhood, B., Najafi, M., Salehi, E., Goradel, N. H., Nashtaei, M. S., Khanlarkhani, N., & Mortezaee, K. (2018). Disruption of the redox balance with either oxidative or anti-oxidative overloading as a promising target for cancer therapy. Journal of Cellular Biochemistry.
- Fogoros, S., Choi, M., & Liu, J. R. (2005). Inhibition of NF-kB enhances chemotherapy induced apoptosis in ovarian cancer cells. Cancer Research, 65(9 Suppl), 1164–1164.
- Fridman, J. S., & Lowe, S. W. (2003). Control of apoptosis by p53. Oncogene, 22, 9030–9040.
- Friedmann-Morvinski, D., Narasimamurthy, R., Xia, Y., Myskiw, C., Soda, Y., & Verma, I. M. (2016). Targeting NF-κB in glioblastoma: A therapeutic approach. Science Advances, 2(1), e1501292.
- Fulda, S. (2009). Tumor resistance to apoptosis. International Journal of Cancer, 124(3), 511–515.
- Fulda, S., & Debatin, K.-M. (2006). Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene, 25(34), 4798–4811.
- Ganjali, S., Blesso, C. N., Banach, M., Pirro, M., Majeed, M., & Sahebkar, A. (2017). Effects of curcumin on HDL functionality. Pharmacological Research, 119, 208–218.
- Garg, A. K., Hortobagyi, G. N., Aggarwal, B. B., Sahin, A. A., & Buchholz, T. A. (2003). Nuclear factor-kappa B as a predictor of treatment response in breast cancer. Current Opinion in Oncology, 15(6), 405–411.
- Ghandadi, M., & Sahebkar, A. (2017). Curcumin: An effective inhibitor of interleukin-6. Current Pharmaceutical Design, 23(6), 921–931.
- Girdhani, S., Ahmed, M. M., & Mishra, K. P. (2009). Enhancement of gamma radiation-induced cytotoxicity of breast cancer cells by curcumin. Molecular and Cellular Pharmacology, 1(4), 208–217.
- Godwin, P., Baird, A. M., Heavey, S., Barr, M. P., O'Byrne, K. J., & Gately, K. (2013). Targeting nuclear factor-kappa B to overcome resistance to chemotherapy. Frontiers in Oncology, 3, 3–120.
- Goel, A., Boland, C. R., & Chauhan, D. P. (2001). Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Letters, 172(2), 111–118.
- Gore, E. (2004). Celecoxib and radiation therapy in non-small-cell lung cancer. Oncology (Williston Park, NY), 18(14 Suppl 14), 10–14.
- Gore, E., Bae, K., Langer, C., Extermann, M., Movsas, B., Okunieff, P., … Choy, H. (2011). Phase I/II trial of a COX-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung cancer: Radiation therapy oncology group 0213. Clinical Lung Cancer, 12(2), 125–130.
- Haimovitz-Friedman, A., Kolesnick, R. N., & Fuks, Z. (1997). Ceramide signaling in apoptosis. British Medical Bulletin, 53(3), 539–553.
- Hallman, K., Aleck, K., Dwyer, B., Lloyd, V., Quigley, M., Sitto, N., … Dinda, S. (2017). The effects of turmeric (curcumin) on tumor suppressor protein (p53) and estrogen receptor (ERalpha) in breast cancer cells. Breast Cancer (Dove Medical Press), 9, 153–161.
- Han, X., Xu, B., Beevers, C. S., Odaka, Y., Chen, L., Liu, L., … Huang, S. (2012). Curcumin inhibits protein phosphatases 2A and 5, leading to activation of mitogen-activated protein kinases and death in tumor cells. Carcinogenesis, 33(4), 868–875.
- Hayden, M. S., & Ghosh, S. (2004). Signaling to NF-κB. Genes & Development, 18(18), 2195–2224.
- Hendry, J. H., & West, C. M. (1997). Apoptosis and mitotic cell death: Their relative contributions to normal-tissue and tumour radiation response. International Journal of Radiation Biology, 71(6), 709–719.
- Hilchie, A. L., Furlong, S. J., Sutton, K., Richardson, A., Robichaud, M. R. J., Giacomantonio, C. A., … Hoskin, D. W. (2010). Curcumin-induced apoptosis in PC3 prostate carcinoma cells is caspase-independent and involves cellular ceramide accumulation and damage to mitochondria. Nutrition and Cancer, 62(3), 379–389.
- Hong, J., Bose, M., Ju, J., Ryu, J.-H., Chen, X., Sang, S., … Yang, C. S. (2004). Modulation of arachidonic acid metabolism by curcumin and related β-diketone derivatives: Effects on cytosolic phospholipase A 2, cyclooxygenases and 5-lipoxygenase. Carcinogenesis, 25(9), 1671–1679.
- Hosseinimehr, S. J. (2010). Flavonoids and genomic instability induced by ionizing radiation. Drug Discovery Today, 15(21-22), 907–918.
- Hu, W., & Kavanagh, J. J. (2003). Anticancer therapy targeting the apoptotic pathway. The Lancet Oncology, 4(12), 721–729.
- Huang, S., Han, X., & Xu, B. (2011). Curcumin induces apoptosis by suppressing protein phosphatase 5 leading to activation of JNK cascade. Federation of American Societies for Experimental Biology, 25(1).
- Huang, W.-C., Chen, C.-L., Lin, Y.-S., & Lin, C.-F. (2011). Apoptotic sphingolipid ceramide in cancer therapy. Journal of Lipids, 2011, 15–15.
10.1155/2011/565316 Google Scholar
- Javvadi, P., Segan, A. T., Tuttle, S. W., & Koumenis, C. (2008). The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased ROS production and overactivation of the MAPK pathway. Molecular Pharmacology, 73, 1491–1501.
- Jin, H., Qiao, F., Wang, Y., Xu, Y., & Shang, Y. (2015). Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway. Oncology Reports, 34(5), 2782–2789.
- Jung, E. M., Lim, J. H., Lee, T. J., Park, J.-W., Choi, K. S., & Kwon, T. K. (2005). Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). Carcinogenesis, 26(11), 1905–1913.
- Jung, E. M., Park, J.-W., Choi, K. S., Park, J.-W., Lee, H. I., Lee, K.-S., & Kwon, T. K. (2006). Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation. Carcinogenesis, 27(10), 2008–2017.
- Kannan, K., & Jain, S. K. (2000). Oxidative stress and apoptosis. Pathophysiology, 7(3), 153–163.
- Karimian, M. S., Pirro, M., Majeed, M., & Sahebkar, A. (2017). Curcumin as a natural regulator of monocyte chemoattractant protein-1. Cytokine and Growth Factor Reviews, 33, 55–63.
- Karin, M. (2006). Nuclear factor-kappaB in cancer development and progression. Nature, 441(7092), 431–436.
- Mortezaee, K., Goradel, N. H., Amini, P., Shabeeb, D., Musa, A. E., Najafi, M., & Farhood, B. (2018). NADPH oxidase as a target for modulation of radiation response; implications to carcinogenesis and radiotherapy. Current Molecular Pharmacology, 12(1). Advance online publication. https://doi.org/10.2174/1874467211666181010154709
- Koeberle, A., Northoff, H., & Werz, O. (2009). Curcumin blocks prostaglandin E2 biosynthesis through direct inhibition of the microsomal prostaglandin E2 synthase-1. Molecular Cancer Therapeutics, 8, 2348–2355.
- Koff, J., Ramachandiran, S., & Bernal-Mizrachi, L. (2015). A time to kill: Targeting apoptosis in cancer. International Journal of Molecular Sciences, 16(2), 2942–2955.
- Koohpar, Z. K., Entezari, M., Movafagh, A., & Hashemi, M. (2015). Anticancer activity of curcumin on human breast adenocarcinoma: Role of Mcl-1 gene. Iranian Journal of Cancer Prevention, 8(3), e2331.
- Kostler, W. J., Hejna, M., Wenzel, C., & Zielinski, C. C. (2001). Oral mucositis complicating chemotherapy and/or radiotherapy: Options for prevention and treatment. CA: A Cancer Journal for Clinicians, 51(5), 290–315.
- Kunnumakkara, A. B., Diagaradjane, P., Guha, S., Deorukhkar, A., Shentu, S., Aggarwal, B. B., & Krishnan, S. (2008). Curcumin sensitizes human colorectal cancer xenografts in nude mice to γ-radiation by targeting nuclear factor-κB–regulated gene products. Clinical Cancer Research, 14(7), 2128–2136.
- Kunnumakkara, A. B., Diagaradjane, P., Anand, P., Kuzhuvelil, H. B., Deorukhkar, A., Gelovani, J., … Aggarwal, B. B. (2009). Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model. International Journal of Cancer, 125(9), 2187–2197.
- Kurose, K., Zhou, X. P., Araki, T., Cannistra, S. A., Maher, E. R., & Eng, C. (2001). Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. The American Journal of Pathology, 158(6), 2097–2106.
- Kwon, D., Oh, S., Park, J.-H., Lee, S., & Lee, S. (2014). The TRAIL sensitization effect of substituted triazolyl curcumin mimics against brain cancer cells. Bulletin of the Korean Chemical Society, 35(11), 3339–3342.
- Kwon, Y. (2016). Mechanism-based management for mucositis: Option for treating side effects without compromising the efficacy of cancer therapy. OncoTargets and Therapy, 9, 2007–2016.
- Lee, S. H., Lee, G. H., Park, S. Y., Lee, S. H., Koo, B. G., Park, O. J., & Kim, Y. M. (2012). Apoptotic effects of curcumin via the regulation of COX-2/VASP signaling molecules in MCF-7 breast cancer cells. Cancer Prevention Research, 17(1), 19–26.
- Lee, Y. K., Park, S. Y., Kim, Y. M., & Park, O. J. (2009). Regulatory effect of the AMPK–COX-2 signaling pathway in curcumin-induced apoptosis in HT-29 colon cancer cells. Annals of the New York Academy of Sciences, 1171(1), 489–494.
- Lelli, D., Sahebkar, A., Johnston, T. P., & Pedone, C. (2017). Curcumin use in pulmonary diseases: State of the art and future perspectives. Pharmacological Research, 115, 133–148.
- Lev-Ari, S., Strier, L., Kazanov, D., Madar-Shapiro, L., Dvory-Sobol, H., Pinchuk, I., … Arber, N. (2005). Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clinical cancer research: An official journal of the American Association for. Cancer Research, 11(18), 6738–6744.
- Lev-Ari, S., Zinger, H., Kazanov, D., Yona, D., Ben-Yosef, R., Starr, A., … Arber, N. (2005). Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells. Biomedicine & Pharmacotherapy, 59, S276–S280.
- Lev-Ari, S., Strier, L., Kazanov, D., Elkayam, O., Lichtenberg, D., Caspi, D., & Arber, N. (2006). Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells. Rheumatology (Oxford, England), 45(2), 171–177.
- Li, F., & Sethi, G. (2010). Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy. Biochimica et Biophysica Acta, 1805(2), 167–180.
- Li, J., Xiang, S., Zhang, Q., Wu, J., Tang, Q., Zhou, J., … Hann, S. S. (2015). Combination of curcumin and bicalutamide enhanced the growth inhibition of androgen-independent prostate cancer cells through SAPK/JNK and MEK/ERK1/2-mediated targeting NF-κB/p65 and MUC1-C. Journal of Experimental & Clinical Cancer Research, 34(1), 46.
- Li, L., Xu-Monette, Z. Y., Ok, C. Y., Tzankov, A., Manyam, G. C., Sun, R., … Young, K. H. (2015). Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma. Oncotarget, 6(27), 23157–23180.
- Li, W., Wang, Y., Song, Y., Xu, L., Zhao, J., & Fang, B. (2015). A preliminary study of the effect of curcumin on the expression of p53 protein in a human multiple myeloma cell line. Oncology Letters, 9(4), 1719–1724.
- Li, X., Xie, W., Xie, C., Huang, C., Zhu, J., Liang, Z., … Zhong, C. (2014). Curcumin modulates miR-19/PTEN/AKT/p53 axis to suppress bisphenol A-induced MCF-7 breast cancer cell proliferation. Phytotherapy Research, 28(10), 1553–1560.
- Lim, W., Jeong, M., Bazer, F. W., & Song, G. (2016). Curcumin suppresses proliferation and migration and induces apoptosis on human placental choriocarcinoma cells via ERK1/2 and SAPK/JNK MAPK signaling pathways. Biology of Reproduction, 95(4), 83–83.
- Madrid, L. V., Wang, C.-Y., Guttridge, D. C., Schottelius, A. J. G., Baldwin, A. S., & Mayo, M. W. (2000). Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-κB. Molecular and Cellular Biology, 20(5), 1626–1638.
- Micheau, O., Lens, S., Gaide, O., Alevizopoulos, K., & Tschopp, J. (2001). NF-κB Signals Induce the Expression of c-FLIP. Molecular and Cellular Biology, 21(16), 5299–5305.
- Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P., & Moll, U. M. (2003). p53 has a direct apoptogenic role at the mitochondria. Molecular Cell, 11(3), 577–590.
- Mirzaei, H., Naseri, G., Rezaee, R., Mohammadi, M., Banikazemi, Z., Mirzaei, H. R., … Sahebkar, A. (2016). Curcumin: A new candidate for melanoma therapy? International Journal of Cancer, 139(8), 1683–1695.
- Mirzaei, H., Masoudifar, A., Sahebkar, A., Zare, N., Sadri Nahand, J., Rashidi, B., … Jaafari, M. R. (2018). MicroRNA: A novel target of curcumin in cancer therapy. Journal of Cellular Physiology, 233(4), 3004–3015.
- Moeller, B. J., Richardson, R. A., & Dewhirst, M. W. (2007). Hypoxia and radiotherapy: Opportunities for improved outcomes in cancer treatment. Cancer and Metastasis Reviews, 26(2), 241–248.
- Momtazi, A. A., Shahabipour, F., Khatibi, S., Johnston, T. P., Pirro, M., & Sahebkar, A. (2016). Curcumin as a MicroRNA regulator in cancer: A review. Reviews of Physiology, Biochemistry and Pharmacology, 171, 1–38.
- Momtazi-Borojeni, A. A., Haftcheshmeh, S. M., Esmaeili, S. A., Johnston, T. P., Abdollahi, E., & Sahebkar, A. (2018). Curcumin: A natural modulator of immune cells in systemic lupus erythematosus. Autoimmunity Reviews, 17(2), 125–135.
- Montagut, C., Tusquets, I., Ferrer, B., Corominas, J. M., Bellosillo, B., Campas, C., … Albanell, J. (2006). Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients. Endocrine-related Cancer, 13(2), 607–616.
- Moos, P. J., Edes, K., Mullally, J. E., & Fitzpatrick, F. A. (2004). Curcumin impairs tumor suppressor p53 function in colon cancer cells. Carcinogenesis, 25(9), 1611–1617.
- Mou, S., Zhou, Z., He, Y., Liu, F., & Gong, L. (2017). Curcumin inhibits cell proliferation and promotes apoptosis of laryngeal cancer cells through Bcl-2 and PI3K/Akt, and by upregulating miR-15a. Oncology Letters, 14(4), 4937–4942.
- Moussavi, M., Assi, K., Gomez-Munoz, A., & Salh, B. (2006). Curcumin mediates ceramide generation via the de novo pathway in colon cancer cells. Carcinogenesis, 27(8), 1636–1644.
- Moustakas, A., & Heldin, C.-H. (2005). Non-Smad TGF-β signals. Journal of Cell Science, 118(16), 3573–3584.
- Moynagh, P. N. (2005). The NF-κB pathway. Journal of Cell Science, 118(20), 4589–4592.
- Mutter, G. L. (2001). Pten, a protean tumor suppressor. The American Journal of Pathology, 158(6), 1895–1898.
- Najafi, M., Hashemi Goradel, N., Farhood, B., Salehi, E., Nashtaei, M. S., Khanlarkhani, N., … Mortezaee, K. (2018). Macrophage polarity in cancer: A review. Journal of Cellular Biochemistry. Advance online publication. https://doi.org/10.1002/jcb.27646
- Najafi, M., Cheki, M., Rezapoor, S., Geraily, G., Motevaseli, E., Carnovale, C., … Shirazi, A. (2018). Metformin: Prevention of genomic instability and cancer: A review. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 827, 1–8.
- Najafi, M., Motevaseli, E., Shirazi, A., Geraily, G., Rezaeyan, A., Norouzi, F., … Abdollahi, H. (2018). Mechanisms of inflammatory responses to radiation and normal tissues toxicity: Clinical implications. International Journal of Radiation Biology, 94(4), 335–356.
- Nakanishi, C., & Toi, M. (2005). Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nature Reviews Cancer, 5(4), 297–309.
- Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., … Nagata, S. (1993). Lethal effect of the anti-Fas antibody in mice. Nature, 364(6440), 806–809.
- Olivera, A., Moore, T. W., Hu, F., Brown, A. P., Sun, A., Liotta, D. C., … Pace, T. W. W. (2012). Inhibition of the NF-kappaB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): Anti-inflammatory and anti-cancer properties. International Immunopharmacology, 12(2), 368–377.
- Orr, W. S., Denbo, J. W., Saab, K. R., Ng, C. Y., Wu, J., Li, K., … Davidoff, A. M. (2013). Curcumin potentiates rhabdomyosarcoma radiosensitivity by suppressing NF-κB activity. PLoS One, 8(2), e51309.
- Panahi, Y., Rahimnia, A. R., Sharafi, M., Alishiri, G., Saburi, A., & Sahebkar, A. (2014). Curcuminoid treatment for knee osteoarthritis: A randomized double-blind placebo-controlled trial. Phytotherapy Research, 28(11), 1625–1631.
- Panahi, Y., Hosseini, M. S., Khalili, N., Naimi, E., Majeed, M., & Sahebkar, A. (2015). Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis. Clinical Nutrition, 34(6), 1101–1108.
- Panahi, Y., Kianpour, P., Mohtashami, R., Jafari, R., Simental-Mendía, L., & Sahebkar, A. (2017). Efficacy and safety of phytosomal curcumin in non-alcoholic fatty liver disease: A randomized controlled trial. Drug Research, 67(4), 244–251.
- Panahi, Y., Khalili, N., Sahebi, E., Namazi, S., Karimian, M. S., Majeed, M., & Sahebkar, A. (2017). Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: A randomized controlled trial. Inflammopharmacology, 25(1), 25–31.
- Panahi, Y., Khalili, N., Sahebi, E., Namazi, S., Simental-Mendía, L., Majeed, M., & Sahebkar, A. (2018). Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes mellitus: A randomized double-blind placebo-controlled trial. Drug Research, 68(7), 403–409.
- Panganiban, R. A., Snow, A., & Day, R. (2013). Mechanisms of radiation toxicity in transformed and non-transformed cells. International Journal of Molecular Sciences, 14(8), 15931–15958.
- Park, S., Cho, D. H., Andera, L., Suh, N., & Kim, I. (2013). Curcumin enhances TRAIL-induced apoptosis of breast cancer cells by regulating apoptosis-related proteins. Molecular and Cellular Biochemistry, 383(1-2), 39–48.
- Parsamanesh, N., Moossavi, M., Bahrami, A., Butler, A. E., & Sahebkar, A. (2018). Therapeutic potential of curcumin in diabetic complications. Pharmacological Research, 136, 181–193.
- Peña, L. A., Fuks, Z., & Koksnick, R. (1997). Stress-induced apoptosis and the sphingomyelin pathway. Biochemical Pharmacology, 53(5), 615–621.
- Peter, M. E., Hadji, A., Murmann, A. E., Brockway, S., Putzbach, W., Pattanayak, A., & Ceppi, P. (2015). The role of CD95 and CD95 ligand in cancer. Cell Death and Differentiation, 22(4), 549–559.
- Qiao, Q., Jiang, Y., & Li, G. (2013). Inhibition of the PI3K/AKT-NF-κB pathway with curcumin enhanced radiation-induced apoptosis in human Burkitt's lymphoma. Journal of Pharmacological Sciences, 121(4), 247–256.
- Qiu, W., Leibowitz, B., Zhang, L., & Yu, J. (2010). Growth factors protect intestinal stem cells from radiation-induced apoptosis by suppressing PUMA through the PI3K/AKT/p53 axis. Oncogene, 29(11), 1622–1632.
- Rahmani, S., Asgary, S., Askari, G., Keshvari, M., Hatamipour, M., Feizi, A., & Sahebkar, A. (2016). Treatment of non-alcoholic fatty liver disease with curcumin: A randomized placebo-controlled trial. Phytotherapy Research, 30, 1540–1548.
- Rödel, C., Grabenbauer, G. G., Rödel, F., Birkenhake, S., Kühn, R., Martus, P., … Sauer, R. (2000). Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: Possible predictors for response to radiochemotherapy and successful bladder preservation. International Journal of Radiation Oncology, Biology, Physics, 46(5), 1213–1221.
- Sah, N. K., Munshi, A., Kurland, J. F., McDonnell, T. J., Su, B., & Meyn, R. E. (2003). Translation inhibitors sensitize prostate cancer cells to apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by activating c-Jun N-terminal kinase. Journal of Biological Chemistry, 278(23), 20593–20602.
- Saha, S., Adhikary, A., Bhattacharyya, P., Das, T., & Sa, G. (2012). Death by design: Where curcumin sensitizes drug-resistant tumours. Anticancer Research, 32(7), 2567–2584.
- Sahebkar, A., & Henrotin, Y. (2016). Analgesic efficacy and safety of curcuminoids in clinical practice: A systematic review and meta-analysis of randomized controlled trials. Pain Medicine (United States), 17(6), 1192–1202.
- Sahebkar, A., Serban, M. C., Ursoniu, S., & Banach, M. (2015). Effect of curcuminoids on oxidative stress: A systematic review and meta-analysis of randomized controlled trials. Journal of Functional Foods, 18, 898–909.
- Sahebkar, A., Cicero, A. F. G., Simental-Mendía, L. E., Aggarwal, B. B., & Gupta, S. C. (2016). Curcumin downregulates human tumor necrosis factor-α levels: A systematic review and meta-analysis ofrandomized controlled trials. Pharmacological Research, 107, 234–242.
- Said Salem, N. I., Noshy, M. M., & Said, A. A. (2017). Modulatory effect of curcumin against genotoxicity and oxidative stress induced by cisplatin and methotrexate in male mice. Food and Chemical Toxicology, 105, 370–376.
- Sayers, T. J. (2011). Targeting the extrinsic apoptosis signaling pathway for cancer therapy. Cancer Immunology, Immunotherapy, 60(8), 1173–1180.
- Schuster, N., & Krieglstein, K. (2002). Mechanisms of TGF-β-mediated apoptosis. Cell and Tissue Research, 307(1), 1–14.
- Shakibaei, M., Mobasheri, A., Lueders, C., Busch, F., Shayan, P., & Goel, A. (2013). Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-kappaB and Src protein kinase signaling pathways. PLoS One, 8(2), e57218.
- Shakibaei, M., Kraehe, P., Popper, B., Shayan, P., Goel, A., & Buhrmann, C. (2015). Curcumin potentiates antitumor activity of 5-fluorouracil in a 3D alginate tumor microenvironment of colorectal cancer. BMC Cancer, 15, 250.
- Shankar, S., & Srivastava, R. (2007). Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer. International Journal of Oncology, 30(4), 905–918.
- Shankar, S., Ganapathy, S., Chen, Q., & Srivastava, R. K. (2008). Curcumin sensitizes TRAIL-resistant xenografts: Molecular mechanisms of apoptosis, metastasis and angiogenesis. Molecular Cancer, 7(1), 16.
- Shankar, S., Chen, Q., Sarva, K., Siddiqui, I., & Srivastava, R. K. (2007). Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: Molecular mechanisms of apoptosis, migration and angiogenesis. Journal of Molecular Signaling, 2(1), 10.
- Siegel, R. L., Miller, K. D., & Jemal, A. (2017). Cancer statistics, 2017. CA: A Cancer Journal for Clinicians, 67(1), 7–30.
- Skinner, H. D., Crane, C. H., Garrett, C. R., Eng, C., Chang, G. J., Skibber, J. M., … Das, P. (2013). Metformin use and improved response to therapy in rectal cancer. Cancer Medicine, 2(1), 99–107.
- Slee, E. A., Harte, M. T., Kluck, R. M., Wolf, B. B., Casiano, C. A., Newmeyer, D. D., … Martin, S. J. (1999). Ordering the cytochrome c–initiated caspase cascade: Hierarchical activation of caspases-2,-3,-6,-7,-8, and-10 in a caspase-9–dependent manner. The Journal of Cell Biology, 144(2), 281–292.
- Somasundaram, S., Edmund, N. A., Moore, D. T., Small, G. W., Shi, Y. Y., & Orlowski, R. Z. (2002). Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Research, 62(13), 3868–3875.
- Sun, H., Lesche, R., Li, D. M., Liliental, J., Zhang, H., Gao, J., … Wu, H. (1999). PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proceedings of the National Academy of Sciences of the United States of America, 96(11), 6199–6204.
- Thompson, H. J., Strange, R., & Schedin, P. J. (1992). Apoptosis in the genesis and prevention of cancer. Cancer epidemiology, biomarkers & prevention: A publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive. Oncology, 1(7), 597–602.
- Tian, F., Fan, T., Zhang, Y., Jiang, Y., & Zhang, X. (2012). Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-kappaB signaling pathway in vitro and in vivo. Acta Biochimica et Biophysica Sinica, 44(10), 847–855.
- Tian, F., Zhang, C., Tian, W., Jiang, Y., & Zhang, X. (2012). Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice. Oncology Reports, 28(1), 232–240.
- Tornatore, L., Sandomenico, A., Raimondo, D., Low, C., Rocci, A., Tralau-Stewart, C., … Franzoso, G. (2014). Cancer-selective targeting of the NF-kappaB survival pathway with GADD45beta/MKK7 inhibitors. Cancer Cell, 26(4), 495–508.
- Tsolou, A., Liousia, M., Kalamida, D., Pouliliou, S., Giatromanolaki, A., & Koukourakis, M. (2017). Inhibition of IKK-NFκB pathway sensitizes lung cancer cell lines to radiation. Cancer Biology & Medicine, 14(3), 293–301.
- Vageli, D. P., Doukas, S. G., Spock, T., & Sasaki, C. T. (2018). Curcumin prevents the bile reflux-induced NF-κB-related mRNA oncogenic phenotype, in human hypopharyngeal cells. Journal of Cellular and Molecular Medicine, 22(9), 4209–4220.
- Vasudevan, K. M., Gurumurthy, S., & Rangnekar, V. M. (2004). Suppression of PTEN expression by NF-κB prevents apoptosis. Molecular and Cellular Biology, 24(3), 1007–1021.
- Vazquez, F., & Sellers, W. R. (2000). The PTEN tumor suppressor protein: An antagonist of phosphoinositide 3-kinase signaling. Biochimica et Biophysica Acta, 1470(1), M21–M35.
- Wahl, H., Tan, L., Griffith, K., Choi, M., & Liu, J. (2007). Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells. Gynecologic Oncology, 105(1), 104–112.
- Wang, S., & El-Deiry, W. S. (2003). TRAIL and apoptosis induction by TNF-family death receptors. Oncogene, 22(53), 8628–8633.
- Wang, W. Z., Li, L., Liu, M. Y., Jin, X. B., Mao, J. W., Pu, Q. H., … Zhu, J. Y. (2013). Curcumin induces FasL-related apoptosis through p38 activation in human hepatocellular carcinoma Huh7 cells. Life Sciences, 92(6-7), 352–358.
- Wang, X., Hang, Y., Liu, J., Hou, Y., Wang, N., & Wang, M. (2017). Anticancer effect of curcumin inhibits cell growth through miR-21/PTEN/Akt pathway in breast cancer cell. Oncology Letters, 13(6), 4825–4831.
- Wang, X., Wei, L., Cramer, J. M., Leibowitz, B. J., Judge, C., Epperly, M., … Yu, J. (2017). Pharmacologically blocking p53-dependent apoptosis protects intestinal stem cells and mice from radiation. Scientific Reports, 5, 8566.
- Wei, Y., Yang, P., Cao, S., & Zhao, L. (2018). The combination of curcumin and 5-fluorouracil in cancer therapy. Archives of Pharmacal Research, 41(1), 1–13.
- Wu, S.-H., Hang, L.-W., Yang, J.-S., Chen, H.-Y., Lin, H.-Y., Chiang, J.-H., … Chung, J.-G. (2010). Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade- and mitochondria-dependent pathways. Anticancer Research, 30(6), 2125–2133.
- Yabu, T., Shiba, H., Shibasaki, Y., Nakanishi, T., Imamura, S., Touhata, K., & Yamashita, M. (2014). Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signaling. Cell Death and Differentiation, 22, 258–273.
- Yahyapour, R., Salajegheh, A., Safari, A., Rezaeyan, A., Amraee, A., & Najafi, M. (2018). Radiation-induced non-targeted effect and carcinogenesis; implications in clinical radiotherapy. Journal of Biomedical Physics and Engineering, 8, 435–446.
- Yahyapour, R., Amini, P., Saffar, H., Rezapoor, S., Motevaseli, E., Cheki, M., … Najafi, M. (2018). Metformin protects against radiation-induced heart injury and attenuates the up-regulation of dual oxidase genes following rat's chest irradiation. International Journal of Molecular and Cellular Medicine, 7(3), 0–0.
- Yahyapour, R., Shabeeb, D., Cheki, M., Musa, A. E., Farhood, B., Rezaeyan, A., … Najafi, M. (2018). Radiation protection and mitigation by natural antioxidants and flavonoids; implications to radiotherapy and radiation disasters. Current Molecular Pharmacology, 11, 285–304.
- Yallapu, M. M., Maher, D. M., Sundram, V., Bell, M. C., Jaggi, M., & Chauhan, S. C. (2010). Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. Journal of Ovarian Research, 3(1), 11.
- Yang, C.-W., Chang, C.-L., Lee, H.-C., Chi, C.-W., Pan, J.-P., & Yang, W.-C. (2012). Curcumin induces the apoptosis of human monocytic leukemia THP-1 cells via the activation of JNK/ERK Pathways. BMC Complementary and Alternative Medicine, 12(1), 22.
- Yang, X., Li, Z., Wu, Q., Chen, S., Yi, C., & Gong, C. (2017). TRAIL and curcumin codelivery nanoparticles enhance TRAIL-induced apoptosis through upregulation of death receptors. Drug Delivery, 24(1), 1526–1536.
- Yao, Q., Ye, X., Wang, L., Gu, J., Fu, T., Wang, Y., … Guo, Y. (2013). Protective effect of curcumin on chemotherapy-induced intestinal dysfunction. International Journal of Clinical and Experimental Pathology, 6(11), 2342–2349.
- Yu, T., Ji, J., & Guo, Y. (2013). MST1 activation by curcumin mediates JNK activation, Foxo3a nuclear translocation and apoptosis in melanoma cells. Biochemical and Biophysical Research Communications, 441(1), 53–58.
- Zabihi, N. A., Pirro, M., Johnston, T. P., & Sahebkar, A. (2017). Is there a role for curcumin supplementation in the treatment of non-alcoholic fatty liver disease? The data suggest yes. Current Pharmaceutical Design, 23(7), 969–982.
- Zhan, Y., Xu, C., Liu, Z., Yang, Y., Tan, S., Yang, Y., … Wu, B. (2016). β-Arrestin1 inhibits chemotherapy-induced intestinal stem cell apoptosis and mucositis. Cell Death and Disease, 7, e2229.
- Zhang, F., Altorki, N. K., Mestre, J. R., Subbaramaiah, K., & Dannenberg, A. J. (1999). Curcumin inhibits cyclooxygenase-2 transcription in bile acid-and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis, 20(3), 445–451.
- Zhang, L., Ding, X., Huang, J., Jiang, C., Cao, B., Qian, Y., … Shao, J. (2015). In vivo radiosensitization of human glioma U87 cells induced by upregulated expression of DUSP-2 after treatment with curcumin. Current Signal Transduction Therapy, 10(2), 119–125.
10.2174/1574362410666150109223303 Google Scholar
- Zhang, M., Xu-Monette, Z. Y., Li, L., Manyam, G. C., Visco, C., Tzankov, A., … Young, K. H. (2016). RelA NF-kappaB subunit activation as a therapeutic target in diffuse large B-cell lymphoma. Aging, 8(12), 3321–3340.
- Zhang, W., Bai, W., & Zhang, W. (2014). MiR-21 suppresses the anticancer activities of curcumin by targeting PTEN gene in human non-small cell lung cancer A549 cells. Clinical and Translational Oncology, 16(8), 708–713.
- Zhu, Y., & Bu, S. (2017). Curcumin induces autophagy, apoptosis, and cell cycle arrest in human pancreatic cancer cells. Evidence-Based Complementary and Alternative Medicine, 2017, 5787218.
